Iovance Biotherapeutics, Inc. (IOVA) Social Stream
IOVANCE BIOTHERAPEUTICS INC (IOVA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering IOVA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 11 | $60 | $20 | $39.7 | $9.91 | 300.61% |
| 2021-11-14 | 10 | $60 | $20 | $39.7 | $9.91 | 300.61% |
| 2021-11-15 | 10 | $60 | $20 | $39 | $9.91 | 293.54% |
| 2022-01-17 | 10 | $60 | $20 | $37.9 | $9.91 | 282.44% |
| 2022-01-28 | 10 | $60 | $20 | $38.1 | $9.91 | 284.46% |
| 2022-02-25 | 10 | $60 | $20 | $36.8 | $9.91 | 271.34% |
| 2022-02-27 | 10 | $60 | $20 | $36.3 | $9.91 | 266.3% |
| 2022-04-07 | 10 | $60 | $20 | $35.909 | $9.91 | 262.35% |
| 2022-05-06 | 9 | $45 | $20 | $33.5 | $9.91 | 238.04% |
| 2022-05-09 | 9 | $44 | $20 | $32.666 | $9.91 | 229.63% |
| 2022-05-26 | 9 | $64 | $13 | $34.2 | $9.91 | 245.11% |
| 2022-05-27 | 9 | $64 | $13 | $32.5 | $9.91 | 227.95% |
| 2022-05-31 | 9 | $64 | $13 | $31.2 | $9.91 | 214.83% |
| 2022-07-01 | 9 | $43 | $13 | $25 | $9.91 | 152.27% |
| 2022-08-05 | 10 | $43 | $13 | $26.222 | $9.91 | 164.6% |
| 2022-08-06 | 10 | $43 | $13 | $26.111 | $9.91 | 163.48% |
| 2022-08-18 | 11 | $43 | $13 | $24.9 | $9.91 | 151.26% |
| 2022-08-23 | 11 | $43 | $13 | $24.7 | $9.91 | 149.24% |
| 2022-11-04 | 12 | $43 | $13 | $24.7 | $9.91 | 149.24% |
| 2022-11-11 | 12 | $43 | $13 | $24.2 | $9.91 | 144.2% |
| 2022-11-21 | 13 | $38 | $11 | $22.818 | $9.91 | 130.25% |
| 2022-12-09 | 13 | $38 | $6 | $21.727 | $9.91 | 119.24% |
| 2023-01-23 | 13 | $38 | $6 | $20.818 | $9.91 | 110.07% |
| 2023-01-24 | 13 | $38 | $6 | $20.909 | $9.91 | 110.99% |
| 2023-01-27 | 13 | $38 | $6 | $21.181 | $9.91 | 113.73% |
| 2023-03-01 | 12 | $38 | $6 | $20.272 | $9.91 | 104.56% |
| 2023-03-27 | 12 | $38 | $6 | $20 | $9.91 | 101.82% |
| 2023-04-05 | 13 | $38 | $6 | $20.909 | $9.91 | 110.99% |
| 2023-05-18 | 13 | $38 | $6 | $20.181 | $9.91 | 103.64% |
| 2023-05-23 | 13 | $38 | $6 | $20.454 | $9.91 | 106.4% |
| 2023-05-30 | 13 | $38 | $6 | $20.727 | $9.91 | 109.15% |
| 2023-06-27 | 13 | $38 | $6 | $21.6 | $9.91 | 117.96% |
| 2023-07-10 | 13 | $38 | $6 | $21.9 | $9.91 | 120.99% |
| 2023-08-09 | 13 | $38 | $6 | $21.727 | $9.91 | 119.24% |
| 2023-08-16 | 12 | $38 | $14 | $23 | $9.91 | 132.09% |
| 2023-09-12 | 12 | $38 | $14 | $22.8 | $9.91 | 130.07% |
| 2023-09-15 | 13 | $38 | $14 | $22.8 | $9.91 | 130.07% |
| 2023-09-18 | 13 | $38 | $14 | $22.363 | $9.91 | 125.66% |
| 2023-11-07 | 13 | $38 | $14 | $22.09 | $9.91 | 122.91% |
| 2023-11-08 | 13 | $30 | $14 | $21.181 | $9.91 | 113.73% |
| 2023-11-20 | 14 | $30 | $12 | $20.416 | $9.91 | 106.01% |
The Trend in the Analyst Price Target
IOVA's average price target has moved down $0.4 over the prior 44 weeks.
Over the past 44 weeks, IOVA's average upside potential has been 205.04%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-16 | 13 | 38 | 6 | 20.818 | 6.35 | 227.84% |
| 2023-01-27 | 12 | 38 | 6 | 21.181 | 8.16 | 159.57% |
| 2023-03-27 | 12 | 38 | 6 | 20.000 | 6.15 | 225.2% |
| 2023-05-10 | 13 | 38 | 6 | 20.454 | 7.64 | 167.72% |
| 2023-09-12 | 12 | 38 | 14 | 22.800 | 5.96 | 282.55% |
IOVA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.14 | 13 | 0 | 1 | 0 | 0 | 14 |
The Trend in the Broker Recommendations
Over the past 44 months, IOVA's average broker recommendation rating worsened by 0.06.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IOVA as an investment opportunity.
- IOVA has a lower variance in analysts' estimates than -4480.98% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, IOVANCE BIOTHERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 4247.44% of them.
- IOVA has a higher number of analysts covering the stock than 3923.39% of stocks in the mid market cap category.
- IOVANCE BIOTHERAPEUTICS INC's average analyst price target is higher than 1918.09% of stocks in the mid market cap category.
In the Pharmaceutical Products industry, ALVR, KYMR, and BCAB are the three stocks most similar to IOVANCE BIOTHERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding IOVA using the data that counts. Try POWR Ratings for free.